SavedAdd your journal

Journals / Acta Orthopaedica et Traumatologica Turcica / 2015 / Cilt: 49 - Sayı: 6

Effect of pentoxifylline on healing of segmental bone defects and angiogenesis

Gökhan ÇAKMAK
Mehmet Şükrü ŞAHİN
B. Handan ÖZDEMİR
EMRE KARADENİZ
Pages
676–682
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Cluster of differentiation 31 (CD31) and vascular endothelial growth factor (VEGF) levels were higher in Group 2 than in Groups 3 and 4.Conclusion: According to radiological and histological parameters, PTX appears to improve angiogenesis and healing of segmental cortical bone defects of the radius in a rat model.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective:The aim of this study was to determine the effect of PTX through angiogenesis on the healing of criticalsized segmental defects of the radius diaphysis in a rat model, using radiological and histological grading systems.
📊
Key Findings & Data:Objective: The aim of this study was to determine the effect of pentoxifylline (PTX) on angiogenesis and the healing of a critical-sized segmental defect of the radius diaphysis in a rat model, using radiological and histological grading systems.Methods: The study included 24 female Sprague-Dawley rats (weight: 300±20 g) divided into 4 groups.
💡
Conclusion & Impact:Cluster of differentiation 31 (CD31) and vascular endothelial growth factor (VEGF) levels were higher in Group 2 than in Groups 3 and 4.Conclusion: According to radiological and histological parameters, PTX appears to improve angiogenesis and healing of segmental cortical bone defects of the radius in a rat model.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective:The aim of this study was to determine the effect of PTX through angiogenesis on the healing of criticalsized segmental defects of the radius diaphysis in a rat model, using radiological and histological grading systems. Objective: The aim of this study was to determine the effect of pentoxifylline (PTX) on angiogenesis and the healing of a critical-sized segmental defect of the radius diaphysis in a rat model, using radiological and histological grading systems.Methods: The study included 24 female Sprague-Dawley rats (weight: 300±20 g) divided into 4 groups. A critical-sized segmental defect was created in the radius diaphysis in all rats. In Group 1, morcellized iliac crest autografts were used to fill the segmental bone defect. In Group 2, segmental bone defects were filled using morcellized iliac crest autografts, and 25 mg/kg/day PTX was applied intraperitoneally. In Group 3, the segmental bone defects were not filled, and in Group 4 the segmental bone defects were left unfilled, and an intraperitoneal (IP) dose of 25 mg/kg/day PTX was applied. Rats were sacrificed at postoperative Week 8, and defects were evaluated using radiographic, histological and immunohistochemical methods.Results: There were significant differences between Group 1 and 2 according to radiological evaluation (p=0.003) and quality of union at the defect site (p=0.01). Union quality was higher in Group 4 than Group 3 (p=0.01). Cluster of differentiation 31 (CD31) and vascular endothelial growth factor (VEGF) levels were higher in Group 2 than in Groups 3 and 4.Conclusion: According to radiological and histological parameters, PTX appears to improve angiogenesis and healing of segmental cortical bone defects of the radius in a rat model.

🔖

Cite This Article

ÇAKMAK, G., ŞAHİN, M. Ş., ÖZDEMİR, B. H., KARADENİZ, E. (2015). Effect of pentoxifylline on healing of segmental bone defects and angiogenesis. Acta Orthopaedica et Traumatologica Turcica, Cilt: 49 - Sayı: 6, 676–682. https://ajindex.com/articles/212555

References (11)

  1. Zhu DJ, Xia B, Bi Q, Zhang SJ, Qiu BS, Zhao C. Func- tional protection of pentoxifylline against spinal cord isch- emia/reperfusion injury in rabbits: necrosis and apoptosis effects. Chin Med J (Engl) 2008;121:2444-9.
  2. Kishi M, Tanaka H, Seiyama A, Takaoka M, Matsuoka T, Yoshioka T, et al. Pentoxifylline attenuates reperfusion in- jury in skeletal muscle after partial ischemia. Am J Physiol 1998;274:H1435-42. Emrecan B, Tulukoğlu E, Bozok S, Aksun M, Yağdi S, Oz- can AV, et al. Iloprost and pentoxifylline attenuate isch- emia-reperfusion injury in skeletal muscle in rabbit model. Ulus Travma Acil Cerrahi Derg 2008;14:182-7.
  3. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res 1994;301:302-12.
  4. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine (Phila Pa 1976) 2000;25:376. Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am 2001;83-A:803-16.
  5. Ozturk AM, Cila E, Kanatli U, Isik I, Senkoylu A, Uzu- nok D, Piskin E. Treatment of segmental bone defects in rats by the stimulation of bone marrow osteo-progenitor cells with prostaglandin E2. Int Orthop 2005;29:73-7.
  6. Cakmak G, Bolukbasi S, Simsek A, Erdem O, Yilmaz G, Senkoylu A. Effect of synthetic cell-binding peptide on the healing of cortical segmental bone defects. Saudi Med J 2006;27:777-80.
  7. Bostrom M, Lane JM, Tomin E, Browne M, Berberian W, Turek T, et al. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop Relat Res 1996;327:272-82.
  8. Bostrom MP, Yang X, Kennan M, Sandhu H, Dicarlo E, Lane JM. An unexpected outcome during testing of com- mercially available demineralized bone graft materials: how safe are the nonallograft components? Spine (Phila Pa 1976) 2001;26:1425-8.
  9. Brighton CT, Hunt RM. Early histological and ultrastruc- tural changes in medullary fracture callus. J Bone Joint Surg Am 1991;73:832-47.
  10. Huss WJ, Hanrahan CF, Barrios RJ, Simons JW, Green- berg NM. Angiogenesis and prostate cancer: identifi- cation of a molecular progression switch. Cancer Res 2001;61:2736-43.
  11. Vecchi A, Garlanda C, Lampugnani MG, Resnati M, Mat- teucci C, Stoppacciaro A, et al. Monoclonal antibodies specific for endothelial cel